BG Medicine Company Profile (NASDAQ:BGMD)

About BG Medicine (NASDAQ:BGMD)

BG Medicine logoBG Medicine, Inc. (BG Medicine) is a commercial-stage diagnostics company. The Company is engaged in commercializing diagnostic products that may be used to help guide the care and management of patients suffering from heart failure and related disorders. The Company's BGM Galectin-3 Test is an in vitro diagnostic device that employs a manual micro-titer platform to measure galectin-3 levels in blood plasma or serum for use as an aid in assessing the prognosis of chronic heart failure in conjunction with clinical evaluation. The automated galectin-3 tests are being developed and commercialized by its diagnostic instrument manufacturing partners and will be performed on its partners' automated platforms. The Company's CardioSCORE test is a multi-analyte biomarker-based blood test that was designed as an aid in the assessment of near-term risk for atherothrombotic cardiovascular events, such as heart attack and ischemic stroke.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Medical Laboratories & Research
  • Sub-Industry: Life Sciences Tools & Services
  • Symbol: NASDAQ:BGMD
  • CUSIP: 08861T10
  • Web:
Average Prices:
  • 50 Day Moving Avg: $0.05
  • 200 Day Moving Avg: $0.06
  • 52 Week Range: $0.03 - $0.18
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 0.51
  • P/E Growth: 0.000
Sales & Book Value:
  • Annual Revenue: $1.57 million
  • Price / Sales: 0.30
  • Book Value: ($0.18) per share
  • Price / Book: -0.23
  • EBITDA: ($4,390,000.00)
  • Net Margins: -311.03%
  • Return on Assets: -131.82%
  • Average Volume: 4,644 shs.
  • Short Ratio: 2.66

Frequently Asked Questions for BG Medicine (NASDAQ:BGMD)

What is BG Medicine's stock symbol?

BG Medicine trades on the NASDAQ under the ticker symbol "BGMD."

How were BG Medicine's earnings last quarter?

BG Medicine, Inc. (NASDAQ:BGMD) posted its quarterly earnings data on Tuesday, November, 17th. The company reported ($0.27) earnings per share (EPS) for the quarter. The business earned $334 million during the quarter, compared to analysts' expectations of $695 million. View BG Medicine's Earnings History.

Who are some of BG Medicine's key competitors?

Who are BG Medicine's key executives?

BG Medicine's management team includes the folowing people:

  • Harry W. Wilcox III, Chairman of the Board
  • Paul R. Sohmer M.D., President, Chief Executive Officer, Director
  • Stephen P. Hall, Chief Financial Officer, Executive Vice President, Treasurer
  • Aram Adourian Ph.D., Senior Vice President, Chief Scientific Officer
  • Jeffrey R. Luber J.D., Independent Director
  • James F. O'Connor CPA, Independent Director
  • Stelios B. Papadopoulos Ph.D., Independent Director

How do I buy BG Medicine stock?

Shares of BG Medicine can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is BG Medicine's stock price today?

One share of BG Medicine stock can currently be purchased for approximately $0.04.

MarketBeat Community Rating for BG Medicine (NASDAQ BGMD)
Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  45 (Vote Outperform)
Underperform Votes:  33 (Vote Underperform)
Total Votes:  78
MarketBeat's community ratings are surveys of what our community members think about BG Medicine and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for BG Medicine (NASDAQ:BGMD) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A
Consensus Price Target History for BG Medicine (NASDAQ:BGMD)
Price Target History for BG Medicine (NASDAQ:BGMD)
Analysts' Ratings History for BG Medicine (NASDAQ:BGMD)
No equities research coverage for this company has been tracked by


Earnings History for BG Medicine (NASDAQ:BGMD)
Earnings by Quarter for BG Medicine (NASDAQ:BGMD)
Earnings History by Quarter for BG Medicine (NASDAQ BGMD)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/17/2015Q315($0.27)$695.00 million$334.00 millionViewN/AView Earnings Details
8/14/2015Q2($0.23)$0.51 millionViewListenView Earnings Details
5/14/2015Q115($0.03)($0.04)$1.60 million$0.44 millionViewListenView Earnings Details
3/31/2015Q414($0.05)($0.04)$0.55 millionViewN/AView Earnings Details
8/14/2014Q214($0.06)($0.06)$1.40 million$2.20 millionViewN/AView Earnings Details
5/14/2014Q114($0.08)($0.08)$1.30 million$0.74 millionViewN/AView Earnings Details
3/20/2014Q413($0.12)($0.06)$1.10 million$1.15 millionViewN/AView Earnings Details
8/8/2013Q2 2013($0.20)($0.18)$1.27 million$1.00 millionViewN/AView Earnings Details
5/9/2013Q1 2013($0.27)($0.21)$1.16 million$0.89 millionViewN/AView Earnings Details
11/13/2012Q312($0.33)($0.34)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for BG Medicine (NASDAQ:BGMD)
Current Year EPS Consensus Estimate: $-0.100 EPS
Next Year EPS Consensus Estimate: $0.080 EPS


Dividend History for BG Medicine (NASDAQ:BGMD)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading and Institutional Ownership History for BG Medicine (NASDAQ:BGMD)
Insider Trades by Quarter for BG Medicine (NASDAQ:BGMD)
Insider Trades by Quarter for BG Medicine (NASDAQ:BGMD)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/9/2015Noubar AfeyanDirectorSell46,438$0.56$26,005.28View SEC Filing  
12/11/2014Edwin M Kania JrMajor ShareholderSell634,390$0.32$203,004.80View SEC Filing  
1/30/2013Stelios PapadopoulosDirectorBuy250,000$2.00$500,000.00View SEC Filing  
11/19/2012Brian S PosnerDirectorBuy10,000$1.17$11,700.00View SEC Filing  
11/15/2012Stephane BancelChairmanBuy100,000$1.26$126,000.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for BG Medicine (NASDAQ:BGMD)
Latest Headlines for BG Medicine (NASDAQ:BGMD)
DateHeadline logoSignal Genetics (MGEN) & BG Medicine (NASDAQ:BGMD) Head to Head Review - August 3 at 7:58 AM logoBG Medicine (NASDAQ:BGMD) & Signal Genetics (MGEN) Head to Head Analysis - August 2 at 10:14 AM logoContrasting BG Medicine (BGMD) and Signal Genetics (MGEN) - July 29 at 12:35 PM logoComparing BG Medicine (NASDAQ:BGMD) & Signal Genetics (MGEN) - July 26 at 2:27 PM logoComparing Signal Genetics (MGEN) & BG Medicine (NASDAQ:BGMD) - July 26 at 12:26 AM logoSignal Genetics (MGEN) versus BG Medicine (BGMD) Financial Survey - July 24 at 9:25 AM logoHead-To-Head Contrast: Miragen Therapeutics (MGEN) & BG Medicine (BGMD) - July 23 at 4:21 PM logoBG Medicine (NASDAQ:BGMD) versus Signal Genetics (MGEN) Head-To-Head Review - July 7 at 8:08 AM logoBG MEDICINE, INC. Files SEC form 10-K, Annual Report - April 4 at 5:02 PM logoBG MEDICINE, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Other Events - March 31 at 5:06 PM logoBG MEDICINE, INC. Files SEC form 8-K, Change in Directors or Principal Officers - February 4 at 5:05 PM logoBG MEDICINE, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits - December 23 at 7:58 AM logoBG MEDICINE, INC. Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Financial Statements and Exhibit - December 4 at 5:04 PM logoBG MEDICINE, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits - November 30 at 7:50 AM logoBG MEDICINE, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; - November 23 at 4:25 PM logoBG MEDICINE, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits - November 20 at 5:02 PM logoBG MEDICINE, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financial Statemen - November 17 at 8:02 AM logoBG MEDICINE, INC. Files SEC form 10-Q, Quarterly Report - November 16 at 5:16 PM



BG Medicine (BGMD) Chart for Thursday, October, 19, 2017

This page was last updated on 10/19/2017 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.